Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0002046701-26-000003
Filing Date
2026-01-09
Accepted
2026-01-09 08:09:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 7164
  Complete submission text file 0002046701-26-000003.txt   9015
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Subject) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90023 | Film No.: 26521384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 99-13 MASAN-GIL, MIYANG-MYEON ANSEONG-SI, GYEONGGI-DO MA 17601
Business Address 99-13 MASAN-GIL, MIYANG-MYEON ANSEONG-SI, GYEONGGI-DO MA 17601 821062202280
Exicure HiTron Inc. (Filed by) CIK: 0002046701 (see all company filings)

EIN.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A